Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangyan Yi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|January 4, 2020
Metal-free C-C, C-O, C-S and C-N bond formation enabled by SBA-15 supported TFMSAXiangyan Yi, Jiajun Feng, Fei Huang, et al.
JACS Au|December 30, 2024
A Collection of Useful Nuisance Compounds (CONS) for Interrogation of Bioassay IntegrityHuabin Hu, Xiangyan Yi, Lian Xue, et al.
Future Medicinal Chemistry|February 18, 2020
Action plan for hit identification (APHID): KAT6A as a case studyXiangyan Yi, Lian Xue, Tim Thomas, et al.
ACS Chemical Biology|June 13, 2023
Meeting Proceedings from ICBS 2022 - <i>Uncovering Solutions for Diseases</i>Joel L Syphers, Lian Xue, Xiangyan Yi, et al.
European Journal of Medicinal Chemistry|January 10, 2024
The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonistsXiangyan Yi, Eric Tran, Jephthah O Odiba, et al.
European Journal of Medicinal Chemistry|January 6, 2026
Promiscuously bioactive compounds are prevalent in widely used commercial drug repurposing librariesHuabin Hu, James Bowers, Justin Shumate, et al.
Pharmacology & Therapeutics|October 28, 2025
Formylpeptide receptors: A novel target to treat cardiometabolic complicationsChen Huei Leo, Elizabeth A Vecchio, Ting Fu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|January 4, 2020
Metal-free C-C, C-O, C-S and C-N bond formation enabled by SBA-15 supported TFMSAXiangyan Yi, Jiajun Feng, Fei Huang, et al.
JACS Au|December 30, 2024
A Collection of Useful Nuisance Compounds (CONS) for Interrogation of Bioassay IntegrityHuabin Hu, Xiangyan Yi, Lian Xue, et al.
Future Medicinal Chemistry|February 18, 2020
Action plan for hit identification (APHID): KAT6A as a case studyXiangyan Yi, Lian Xue, Tim Thomas, et al.
ACS Chemical Biology|June 13, 2023
Meeting Proceedings from ICBS 2022 - <i>Uncovering Solutions for Diseases</i>Joel L Syphers, Lian Xue, Xiangyan Yi, et al.
European Journal of Medicinal Chemistry|January 10, 2024
The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonistsXiangyan Yi, Eric Tran, Jephthah O Odiba, et al.
European Journal of Medicinal Chemistry|January 6, 2026
Promiscuously bioactive compounds are prevalent in widely used commercial drug repurposing librariesHuabin Hu, James Bowers, Justin Shumate, et al.
Pharmacology & Therapeutics|October 28, 2025
Formylpeptide receptors: A novel target to treat cardiometabolic complicationsChen Huei Leo, Elizabeth A Vecchio, Ting Fu, et al.
Pageof 1